Global Monoclonal Antibody Drug Supply, Demand and Key Producers, 2023-2029
The global Monoclonal Antibody Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Monoclonal Antibody Drug demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Monoclonal Antibody Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Monoclonal Antibody Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Monoclonal Antibody Drug total market, 2018-2029, (USD Million)
Global Monoclonal Antibody Drug total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Monoclonal Antibody Drug total market, key domestic companies and share, (USD Million)
Global Monoclonal Antibody Drug revenue by player and market share 2018-2023, (USD Million)
Global Monoclonal Antibody Drug total market by Type, CAGR, 2018-2029, (USD Million)
Global Monoclonal Antibody Drug total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Monoclonal Antibody Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Johnson & Johnson, Roche, Ono Pharmaceutical, Amgen, Merck, Jiangsu Hengrui Pharmaceuticals, Beigene and Shanghai Junshi Biosciences, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Monoclonal Antibody Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Monoclonal Antibody Drug Market, By Region:
1. How big is the global Monoclonal Antibody Drug market?
2. What is the demand of the global Monoclonal Antibody Drug market?
3. What is the year over year growth of the global Monoclonal Antibody Drug market?
4. What is the total value of the global Monoclonal Antibody Drug market?
5. Who are the major players in the global Monoclonal Antibody Drug market?
6. What are the growth factors driving the market demand?
This report studies the global Monoclonal Antibody Drug demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Monoclonal Antibody Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Monoclonal Antibody Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Monoclonal Antibody Drug total market, 2018-2029, (USD Million)
Global Monoclonal Antibody Drug total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Monoclonal Antibody Drug total market, key domestic companies and share, (USD Million)
Global Monoclonal Antibody Drug revenue by player and market share 2018-2023, (USD Million)
Global Monoclonal Antibody Drug total market by Type, CAGR, 2018-2029, (USD Million)
Global Monoclonal Antibody Drug total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Monoclonal Antibody Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Johnson & Johnson, Roche, Ono Pharmaceutical, Amgen, Merck, Jiangsu Hengrui Pharmaceuticals, Beigene and Shanghai Junshi Biosciences, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Monoclonal Antibody Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Monoclonal Antibody Drug Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Humanized Monoclonal Antibody Drugs
- Fully Human Monoclonal Antibody Drugs
- Small Molecule Antibody Drugs
- Chimeric Monoclonal Antibody Drugs
- Other
- Cancer Treatment
- Autoimmune Disease Treatment
- Abbott
- Johnson & Johnson
- Roche
- Ono Pharmaceutical
- Amgen
- Merck
- Jiangsu Hengrui Pharmaceuticals
- Beigene
- Shanghai Junshi Biosciences
- Innovent Biologics
- WuXi Biologics (Cayman)
- Shanghai Henlius Biotech
- Akeso
- Lepu Biopharma
- CStone Pharmaceuticals
- Hillhouse Investment Management
- Alphamab Oncology
- Novartis
- Takeda Pharmaceutical
1. How big is the global Monoclonal Antibody Drug market?
2. What is the demand of the global Monoclonal Antibody Drug market?
3. What is the year over year growth of the global Monoclonal Antibody Drug market?
4. What is the total value of the global Monoclonal Antibody Drug market?
5. Who are the major players in the global Monoclonal Antibody Drug market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Monoclonal Antibody Drug Introduction
1.2 World Monoclonal Antibody Drug Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Monoclonal Antibody Drug Total Market by Region (by Headquarter Location)
1.3.1 World Monoclonal Antibody Drug Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Monoclonal Antibody Drug Market Size (2018-2029)
1.3.3 China Monoclonal Antibody Drug Market Size (2018-2029)
1.3.4 Europe Monoclonal Antibody Drug Market Size (2018-2029)
1.3.5 Japan Monoclonal Antibody Drug Market Size (2018-2029)
1.3.6 South Korea Monoclonal Antibody Drug Market Size (2018-2029)
1.3.7 ASEAN Monoclonal Antibody Drug Market Size (2018-2029)
1.3.8 India Monoclonal Antibody Drug Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Monoclonal Antibody Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Monoclonal Antibody Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Monoclonal Antibody Drug Consumption Value (2018-2029)
2.2 World Monoclonal Antibody Drug Consumption Value by Region
2.2.1 World Monoclonal Antibody Drug Consumption Value by Region (2018-2023)
2.2.2 World Monoclonal Antibody Drug Consumption Value Forecast by Region (2024-2029)
2.3 United States Monoclonal Antibody Drug Consumption Value (2018-2029)
2.4 China Monoclonal Antibody Drug Consumption Value (2018-2029)
2.5 Europe Monoclonal Antibody Drug Consumption Value (2018-2029)
2.6 Japan Monoclonal Antibody Drug Consumption Value (2018-2029)
2.7 South Korea Monoclonal Antibody Drug Consumption Value (2018-2029)
2.8 ASEAN Monoclonal Antibody Drug Consumption Value (2018-2029)
2.9 India Monoclonal Antibody Drug Consumption Value (2018-2029)
3 WORLD MONOCLONAL ANTIBODY DRUG COMPANIES COMPETITIVE ANALYSIS
3.1 World Monoclonal Antibody Drug Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Monoclonal Antibody Drug Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Monoclonal Antibody Drug in 2022
3.2.3 Global Concentration Ratios (CR8) for Monoclonal Antibody Drug in 2022
3.3 Monoclonal Antibody Drug Company Evaluation Quadrant
3.4 Monoclonal Antibody Drug Market: Overall Company Footprint Analysis
3.4.1 Monoclonal Antibody Drug Market: Region Footprint
3.4.2 Monoclonal Antibody Drug Market: Company Product Type Footprint
3.4.3 Monoclonal Antibody Drug Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Monoclonal Antibody Drug Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Monoclonal Antibody Drug Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Monoclonal Antibody Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Monoclonal Antibody Drug Consumption Value Comparison
4.2.1 United States VS China: Monoclonal Antibody Drug Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Monoclonal Antibody Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Monoclonal Antibody Drug Companies and Market Share, 2018-2023
4.3.1 United States Based Monoclonal Antibody Drug Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Monoclonal Antibody Drug Revenue, (2018-2023)
4.4 China Based Companies Monoclonal Antibody Drug Revenue and Market Share, 2018-2023
4.4.1 China Based Monoclonal Antibody Drug Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Monoclonal Antibody Drug Revenue, (2018-2023)
4.5 Rest of World Based Monoclonal Antibody Drug Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Monoclonal Antibody Drug Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Monoclonal Antibody Drug Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Monoclonal Antibody Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Humanized Monoclonal Antibody Drugs
5.2.2 Fully Human Monoclonal Antibody Drugs
5.2.3 Small Molecule Antibody Drugs
5.2.4 Chimeric Monoclonal Antibody Drugs
5.2.5 Other
5.3 Market Segment by Type
5.3.1 World Monoclonal Antibody Drug Market Size by Type (2018-2023)
5.3.2 World Monoclonal Antibody Drug Market Size by Type (2024-2029)
5.3.3 World Monoclonal Antibody Drug Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Monoclonal Antibody Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Cancer Treatment
6.2.2 Autoimmune Disease Treatment
6.3 Market Segment by Application
6.3.1 World Monoclonal Antibody Drug Market Size by Application (2018-2023)
6.3.2 World Monoclonal Antibody Drug Market Size by Application (2024-2029)
6.3.3 World Monoclonal Antibody Drug Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Abbott
7.1.1 Abbott Details
7.1.2 Abbott Major Business
7.1.3 Abbott Monoclonal Antibody Drug Product and Services
7.1.4 Abbott Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Abbott Recent Developments/Updates
7.1.6 Abbott Competitive Strengths & Weaknesses
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Details
7.2.2 Johnson & Johnson Major Business
7.2.3 Johnson & Johnson Monoclonal Antibody Drug Product and Services
7.2.4 Johnson & Johnson Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Johnson & Johnson Recent Developments/Updates
7.2.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.3 Roche
7.3.1 Roche Details
7.3.2 Roche Major Business
7.3.3 Roche Monoclonal Antibody Drug Product and Services
7.3.4 Roche Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Roche Recent Developments/Updates
7.3.6 Roche Competitive Strengths & Weaknesses
7.4 Ono Pharmaceutical
7.4.1 Ono Pharmaceutical Details
7.4.2 Ono Pharmaceutical Major Business
7.4.3 Ono Pharmaceutical Monoclonal Antibody Drug Product and Services
7.4.4 Ono Pharmaceutical Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Ono Pharmaceutical Recent Developments/Updates
7.4.6 Ono Pharmaceutical Competitive Strengths & Weaknesses
7.5 Amgen
7.5.1 Amgen Details
7.5.2 Amgen Major Business
7.5.3 Amgen Monoclonal Antibody Drug Product and Services
7.5.4 Amgen Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Amgen Recent Developments/Updates
7.5.6 Amgen Competitive Strengths & Weaknesses
7.6 Merck
7.6.1 Merck Details
7.6.2 Merck Major Business
7.6.3 Merck Monoclonal Antibody Drug Product and Services
7.6.4 Merck Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Merck Recent Developments/Updates
7.6.6 Merck Competitive Strengths & Weaknesses
7.7 Jiangsu Hengrui Pharmaceuticals
7.7.1 Jiangsu Hengrui Pharmaceuticals Details
7.7.2 Jiangsu Hengrui Pharmaceuticals Major Business
7.7.3 Jiangsu Hengrui Pharmaceuticals Monoclonal Antibody Drug Product and Services
7.7.4 Jiangsu Hengrui Pharmaceuticals Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
7.7.6 Jiangsu Hengrui Pharmaceuticals Competitive Strengths & Weaknesses
7.8 Beigene
7.8.1 Beigene Details
7.8.2 Beigene Major Business
7.8.3 Beigene Monoclonal Antibody Drug Product and Services
7.8.4 Beigene Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Beigene Recent Developments/Updates
7.8.6 Beigene Competitive Strengths & Weaknesses
7.9 Shanghai Junshi Biosciences
7.9.1 Shanghai Junshi Biosciences Details
7.9.2 Shanghai Junshi Biosciences Major Business
7.9.3 Shanghai Junshi Biosciences Monoclonal Antibody Drug Product and Services
7.9.4 Shanghai Junshi Biosciences Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Shanghai Junshi Biosciences Recent Developments/Updates
7.9.6 Shanghai Junshi Biosciences Competitive Strengths & Weaknesses
7.10 Innovent Biologics
7.10.1 Innovent Biologics Details
7.10.2 Innovent Biologics Major Business
7.10.3 Innovent Biologics Monoclonal Antibody Drug Product and Services
7.10.4 Innovent Biologics Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Innovent Biologics Recent Developments/Updates
7.10.6 Innovent Biologics Competitive Strengths & Weaknesses
7.11 WuXi Biologics (Cayman)
7.11.1 WuXi Biologics (Cayman) Details
7.11.2 WuXi Biologics (Cayman) Major Business
7.11.3 WuXi Biologics (Cayman) Monoclonal Antibody Drug Product and Services
7.11.4 WuXi Biologics (Cayman) Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 WuXi Biologics (Cayman) Recent Developments/Updates
7.11.6 WuXi Biologics (Cayman) Competitive Strengths & Weaknesses
7.12 Shanghai Henlius Biotech
7.12.1 Shanghai Henlius Biotech Details
7.12.2 Shanghai Henlius Biotech Major Business
7.12.3 Shanghai Henlius Biotech Monoclonal Antibody Drug Product and Services
7.12.4 Shanghai Henlius Biotech Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Shanghai Henlius Biotech Recent Developments/Updates
7.12.6 Shanghai Henlius Biotech Competitive Strengths & Weaknesses
7.13 Akeso
7.13.1 Akeso Details
7.13.2 Akeso Major Business
7.13.3 Akeso Monoclonal Antibody Drug Product and Services
7.13.4 Akeso Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Akeso Recent Developments/Updates
7.13.6 Akeso Competitive Strengths & Weaknesses
7.14 Lepu Biopharma
7.14.1 Lepu Biopharma Details
7.14.2 Lepu Biopharma Major Business
7.14.3 Lepu Biopharma Monoclonal Antibody Drug Product and Services
7.14.4 Lepu Biopharma Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Lepu Biopharma Recent Developments/Updates
7.14.6 Lepu Biopharma Competitive Strengths & Weaknesses
7.15 CStone Pharmaceuticals
7.15.1 CStone Pharmaceuticals Details
7.15.2 CStone Pharmaceuticals Major Business
7.15.3 CStone Pharmaceuticals Monoclonal Antibody Drug Product and Services
7.15.4 CStone Pharmaceuticals Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 CStone Pharmaceuticals Recent Developments/Updates
7.15.6 CStone Pharmaceuticals Competitive Strengths & Weaknesses
7.16 Hillhouse Investment Management
7.16.1 Hillhouse Investment Management Details
7.16.2 Hillhouse Investment Management Major Business
7.16.3 Hillhouse Investment Management Monoclonal Antibody Drug Product and Services
7.16.4 Hillhouse Investment Management Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Hillhouse Investment Management Recent Developments/Updates
7.16.6 Hillhouse Investment Management Competitive Strengths & Weaknesses
7.17 Alphamab Oncology
7.17.1 Alphamab Oncology Details
7.17.2 Alphamab Oncology Major Business
7.17.3 Alphamab Oncology Monoclonal Antibody Drug Product and Services
7.17.4 Alphamab Oncology Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Alphamab Oncology Recent Developments/Updates
7.17.6 Alphamab Oncology Competitive Strengths & Weaknesses
7.18 Novartis
7.18.1 Novartis Details
7.18.2 Novartis Major Business
7.18.3 Novartis Monoclonal Antibody Drug Product and Services
7.18.4 Novartis Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Novartis Recent Developments/Updates
7.18.6 Novartis Competitive Strengths & Weaknesses
7.19 Takeda Pharmaceutical
7.19.1 Takeda Pharmaceutical Details
7.19.2 Takeda Pharmaceutical Major Business
7.19.3 Takeda Pharmaceutical Monoclonal Antibody Drug Product and Services
7.19.4 Takeda Pharmaceutical Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 Takeda Pharmaceutical Recent Developments/Updates
7.19.6 Takeda Pharmaceutical Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Monoclonal Antibody Drug Industry Chain
8.2 Monoclonal Antibody Drug Upstream Analysis
8.3 Monoclonal Antibody Drug Midstream Analysis
8.4 Monoclonal Antibody Drug Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Monoclonal Antibody Drug Introduction
1.2 World Monoclonal Antibody Drug Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Monoclonal Antibody Drug Total Market by Region (by Headquarter Location)
1.3.1 World Monoclonal Antibody Drug Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Monoclonal Antibody Drug Market Size (2018-2029)
1.3.3 China Monoclonal Antibody Drug Market Size (2018-2029)
1.3.4 Europe Monoclonal Antibody Drug Market Size (2018-2029)
1.3.5 Japan Monoclonal Antibody Drug Market Size (2018-2029)
1.3.6 South Korea Monoclonal Antibody Drug Market Size (2018-2029)
1.3.7 ASEAN Monoclonal Antibody Drug Market Size (2018-2029)
1.3.8 India Monoclonal Antibody Drug Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Monoclonal Antibody Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Monoclonal Antibody Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Monoclonal Antibody Drug Consumption Value (2018-2029)
2.2 World Monoclonal Antibody Drug Consumption Value by Region
2.2.1 World Monoclonal Antibody Drug Consumption Value by Region (2018-2023)
2.2.2 World Monoclonal Antibody Drug Consumption Value Forecast by Region (2024-2029)
2.3 United States Monoclonal Antibody Drug Consumption Value (2018-2029)
2.4 China Monoclonal Antibody Drug Consumption Value (2018-2029)
2.5 Europe Monoclonal Antibody Drug Consumption Value (2018-2029)
2.6 Japan Monoclonal Antibody Drug Consumption Value (2018-2029)
2.7 South Korea Monoclonal Antibody Drug Consumption Value (2018-2029)
2.8 ASEAN Monoclonal Antibody Drug Consumption Value (2018-2029)
2.9 India Monoclonal Antibody Drug Consumption Value (2018-2029)
3 WORLD MONOCLONAL ANTIBODY DRUG COMPANIES COMPETITIVE ANALYSIS
3.1 World Monoclonal Antibody Drug Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Monoclonal Antibody Drug Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Monoclonal Antibody Drug in 2022
3.2.3 Global Concentration Ratios (CR8) for Monoclonal Antibody Drug in 2022
3.3 Monoclonal Antibody Drug Company Evaluation Quadrant
3.4 Monoclonal Antibody Drug Market: Overall Company Footprint Analysis
3.4.1 Monoclonal Antibody Drug Market: Region Footprint
3.4.2 Monoclonal Antibody Drug Market: Company Product Type Footprint
3.4.3 Monoclonal Antibody Drug Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Monoclonal Antibody Drug Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Monoclonal Antibody Drug Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Monoclonal Antibody Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Monoclonal Antibody Drug Consumption Value Comparison
4.2.1 United States VS China: Monoclonal Antibody Drug Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Monoclonal Antibody Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Monoclonal Antibody Drug Companies and Market Share, 2018-2023
4.3.1 United States Based Monoclonal Antibody Drug Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Monoclonal Antibody Drug Revenue, (2018-2023)
4.4 China Based Companies Monoclonal Antibody Drug Revenue and Market Share, 2018-2023
4.4.1 China Based Monoclonal Antibody Drug Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Monoclonal Antibody Drug Revenue, (2018-2023)
4.5 Rest of World Based Monoclonal Antibody Drug Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Monoclonal Antibody Drug Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Monoclonal Antibody Drug Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Monoclonal Antibody Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Humanized Monoclonal Antibody Drugs
5.2.2 Fully Human Monoclonal Antibody Drugs
5.2.3 Small Molecule Antibody Drugs
5.2.4 Chimeric Monoclonal Antibody Drugs
5.2.5 Other
5.3 Market Segment by Type
5.3.1 World Monoclonal Antibody Drug Market Size by Type (2018-2023)
5.3.2 World Monoclonal Antibody Drug Market Size by Type (2024-2029)
5.3.3 World Monoclonal Antibody Drug Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Monoclonal Antibody Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Cancer Treatment
6.2.2 Autoimmune Disease Treatment
6.3 Market Segment by Application
6.3.1 World Monoclonal Antibody Drug Market Size by Application (2018-2023)
6.3.2 World Monoclonal Antibody Drug Market Size by Application (2024-2029)
6.3.3 World Monoclonal Antibody Drug Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Abbott
7.1.1 Abbott Details
7.1.2 Abbott Major Business
7.1.3 Abbott Monoclonal Antibody Drug Product and Services
7.1.4 Abbott Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Abbott Recent Developments/Updates
7.1.6 Abbott Competitive Strengths & Weaknesses
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Details
7.2.2 Johnson & Johnson Major Business
7.2.3 Johnson & Johnson Monoclonal Antibody Drug Product and Services
7.2.4 Johnson & Johnson Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Johnson & Johnson Recent Developments/Updates
7.2.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.3 Roche
7.3.1 Roche Details
7.3.2 Roche Major Business
7.3.3 Roche Monoclonal Antibody Drug Product and Services
7.3.4 Roche Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Roche Recent Developments/Updates
7.3.6 Roche Competitive Strengths & Weaknesses
7.4 Ono Pharmaceutical
7.4.1 Ono Pharmaceutical Details
7.4.2 Ono Pharmaceutical Major Business
7.4.3 Ono Pharmaceutical Monoclonal Antibody Drug Product and Services
7.4.4 Ono Pharmaceutical Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Ono Pharmaceutical Recent Developments/Updates
7.4.6 Ono Pharmaceutical Competitive Strengths & Weaknesses
7.5 Amgen
7.5.1 Amgen Details
7.5.2 Amgen Major Business
7.5.3 Amgen Monoclonal Antibody Drug Product and Services
7.5.4 Amgen Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Amgen Recent Developments/Updates
7.5.6 Amgen Competitive Strengths & Weaknesses
7.6 Merck
7.6.1 Merck Details
7.6.2 Merck Major Business
7.6.3 Merck Monoclonal Antibody Drug Product and Services
7.6.4 Merck Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Merck Recent Developments/Updates
7.6.6 Merck Competitive Strengths & Weaknesses
7.7 Jiangsu Hengrui Pharmaceuticals
7.7.1 Jiangsu Hengrui Pharmaceuticals Details
7.7.2 Jiangsu Hengrui Pharmaceuticals Major Business
7.7.3 Jiangsu Hengrui Pharmaceuticals Monoclonal Antibody Drug Product and Services
7.7.4 Jiangsu Hengrui Pharmaceuticals Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
7.7.6 Jiangsu Hengrui Pharmaceuticals Competitive Strengths & Weaknesses
7.8 Beigene
7.8.1 Beigene Details
7.8.2 Beigene Major Business
7.8.3 Beigene Monoclonal Antibody Drug Product and Services
7.8.4 Beigene Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Beigene Recent Developments/Updates
7.8.6 Beigene Competitive Strengths & Weaknesses
7.9 Shanghai Junshi Biosciences
7.9.1 Shanghai Junshi Biosciences Details
7.9.2 Shanghai Junshi Biosciences Major Business
7.9.3 Shanghai Junshi Biosciences Monoclonal Antibody Drug Product and Services
7.9.4 Shanghai Junshi Biosciences Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Shanghai Junshi Biosciences Recent Developments/Updates
7.9.6 Shanghai Junshi Biosciences Competitive Strengths & Weaknesses
7.10 Innovent Biologics
7.10.1 Innovent Biologics Details
7.10.2 Innovent Biologics Major Business
7.10.3 Innovent Biologics Monoclonal Antibody Drug Product and Services
7.10.4 Innovent Biologics Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Innovent Biologics Recent Developments/Updates
7.10.6 Innovent Biologics Competitive Strengths & Weaknesses
7.11 WuXi Biologics (Cayman)
7.11.1 WuXi Biologics (Cayman) Details
7.11.2 WuXi Biologics (Cayman) Major Business
7.11.3 WuXi Biologics (Cayman) Monoclonal Antibody Drug Product and Services
7.11.4 WuXi Biologics (Cayman) Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 WuXi Biologics (Cayman) Recent Developments/Updates
7.11.6 WuXi Biologics (Cayman) Competitive Strengths & Weaknesses
7.12 Shanghai Henlius Biotech
7.12.1 Shanghai Henlius Biotech Details
7.12.2 Shanghai Henlius Biotech Major Business
7.12.3 Shanghai Henlius Biotech Monoclonal Antibody Drug Product and Services
7.12.4 Shanghai Henlius Biotech Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Shanghai Henlius Biotech Recent Developments/Updates
7.12.6 Shanghai Henlius Biotech Competitive Strengths & Weaknesses
7.13 Akeso
7.13.1 Akeso Details
7.13.2 Akeso Major Business
7.13.3 Akeso Monoclonal Antibody Drug Product and Services
7.13.4 Akeso Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Akeso Recent Developments/Updates
7.13.6 Akeso Competitive Strengths & Weaknesses
7.14 Lepu Biopharma
7.14.1 Lepu Biopharma Details
7.14.2 Lepu Biopharma Major Business
7.14.3 Lepu Biopharma Monoclonal Antibody Drug Product and Services
7.14.4 Lepu Biopharma Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Lepu Biopharma Recent Developments/Updates
7.14.6 Lepu Biopharma Competitive Strengths & Weaknesses
7.15 CStone Pharmaceuticals
7.15.1 CStone Pharmaceuticals Details
7.15.2 CStone Pharmaceuticals Major Business
7.15.3 CStone Pharmaceuticals Monoclonal Antibody Drug Product and Services
7.15.4 CStone Pharmaceuticals Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 CStone Pharmaceuticals Recent Developments/Updates
7.15.6 CStone Pharmaceuticals Competitive Strengths & Weaknesses
7.16 Hillhouse Investment Management
7.16.1 Hillhouse Investment Management Details
7.16.2 Hillhouse Investment Management Major Business
7.16.3 Hillhouse Investment Management Monoclonal Antibody Drug Product and Services
7.16.4 Hillhouse Investment Management Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Hillhouse Investment Management Recent Developments/Updates
7.16.6 Hillhouse Investment Management Competitive Strengths & Weaknesses
7.17 Alphamab Oncology
7.17.1 Alphamab Oncology Details
7.17.2 Alphamab Oncology Major Business
7.17.3 Alphamab Oncology Monoclonal Antibody Drug Product and Services
7.17.4 Alphamab Oncology Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Alphamab Oncology Recent Developments/Updates
7.17.6 Alphamab Oncology Competitive Strengths & Weaknesses
7.18 Novartis
7.18.1 Novartis Details
7.18.2 Novartis Major Business
7.18.3 Novartis Monoclonal Antibody Drug Product and Services
7.18.4 Novartis Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Novartis Recent Developments/Updates
7.18.6 Novartis Competitive Strengths & Weaknesses
7.19 Takeda Pharmaceutical
7.19.1 Takeda Pharmaceutical Details
7.19.2 Takeda Pharmaceutical Major Business
7.19.3 Takeda Pharmaceutical Monoclonal Antibody Drug Product and Services
7.19.4 Takeda Pharmaceutical Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 Takeda Pharmaceutical Recent Developments/Updates
7.19.6 Takeda Pharmaceutical Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Monoclonal Antibody Drug Industry Chain
8.2 Monoclonal Antibody Drug Upstream Analysis
8.3 Monoclonal Antibody Drug Midstream Analysis
8.4 Monoclonal Antibody Drug Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Monoclonal Antibody Drug Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Monoclonal Antibody Drug Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Monoclonal Antibody Drug Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Monoclonal Antibody Drug Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Monoclonal Antibody Drug Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Monoclonal Antibody Drug Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Monoclonal Antibody Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Monoclonal Antibody Drug Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Monoclonal Antibody Drug Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Monoclonal Antibody Drug Players in 2022
Table 12. World Monoclonal Antibody Drug Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Monoclonal Antibody Drug Company Evaluation Quadrant
Table 14. Head Office of Key Monoclonal Antibody Drug Player
Table 15. Monoclonal Antibody Drug Market: Company Product Type Footprint
Table 16. Monoclonal Antibody Drug Market: Company Product Application Footprint
Table 17. Monoclonal Antibody Drug Mergers & Acquisitions Activity
Table 18. United States VS China Monoclonal Antibody Drug Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Monoclonal Antibody Drug Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Monoclonal Antibody Drug Companies, Headquarters (States, Country)
Table 21. United States Based Companies Monoclonal Antibody Drug Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Monoclonal Antibody Drug Revenue Market Share (2018-2023)
Table 23. China Based Monoclonal Antibody Drug Companies, Headquarters (Province, Country)
Table 24. China Based Companies Monoclonal Antibody Drug Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Monoclonal Antibody Drug Revenue Market Share (2018-2023)
Table 26. Rest of World Based Monoclonal Antibody Drug Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Monoclonal Antibody Drug Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Monoclonal Antibody Drug Revenue Market Share (2018-2023)
Table 29. World Monoclonal Antibody Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Monoclonal Antibody Drug Market Size by Type (2018-2023) & (USD Million)
Table 31. World Monoclonal Antibody Drug Market Size by Type (2024-2029) & (USD Million)
Table 32. World Monoclonal Antibody Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Monoclonal Antibody Drug Market Size by Application (2018-2023) & (USD Million)
Table 34. World Monoclonal Antibody Drug Market Size by Application (2024-2029) & (USD Million)
Table 35. Abbott Basic Information, Area Served and Competitors
Table 36. Abbott Major Business
Table 37. Abbott Monoclonal Antibody Drug Product and Services
Table 38. Abbott Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Abbott Recent Developments/Updates
Table 40. Abbott Competitive Strengths & Weaknesses
Table 41. Johnson & Johnson Basic Information, Area Served and Competitors
Table 42. Johnson & Johnson Major Business
Table 43. Johnson & Johnson Monoclonal Antibody Drug Product and Services
Table 44. Johnson & Johnson Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Johnson & Johnson Recent Developments/Updates
Table 46. Johnson & Johnson Competitive Strengths & Weaknesses
Table 47. Roche Basic Information, Area Served and Competitors
Table 48. Roche Major Business
Table 49. Roche Monoclonal Antibody Drug Product and Services
Table 50. Roche Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Roche Recent Developments/Updates
Table 52. Roche Competitive Strengths & Weaknesses
Table 53. Ono Pharmaceutical Basic Information, Area Served and Competitors
Table 54. Ono Pharmaceutical Major Business
Table 55. Ono Pharmaceutical Monoclonal Antibody Drug Product and Services
Table 56. Ono Pharmaceutical Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Ono Pharmaceutical Recent Developments/Updates
Table 58. Ono Pharmaceutical Competitive Strengths & Weaknesses
Table 59. Amgen Basic Information, Area Served and Competitors
Table 60. Amgen Major Business
Table 61. Amgen Monoclonal Antibody Drug Product and Services
Table 62. Amgen Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Amgen Recent Developments/Updates
Table 64. Amgen Competitive Strengths & Weaknesses
Table 65. Merck Basic Information, Area Served and Competitors
Table 66. Merck Major Business
Table 67. Merck Monoclonal Antibody Drug Product and Services
Table 68. Merck Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Merck Recent Developments/Updates
Table 70. Merck Competitive Strengths & Weaknesses
Table 71. Jiangsu Hengrui Pharmaceuticals Basic Information, Area Served and Competitors
Table 72. Jiangsu Hengrui Pharmaceuticals Major Business
Table 73. Jiangsu Hengrui Pharmaceuticals Monoclonal Antibody Drug Product and Services
Table 74. Jiangsu Hengrui Pharmaceuticals Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
Table 76. Jiangsu Hengrui Pharmaceuticals Competitive Strengths & Weaknesses
Table 77. Beigene Basic Information, Area Served and Competitors
Table 78. Beigene Major Business
Table 79. Beigene Monoclonal Antibody Drug Product and Services
Table 80. Beigene Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Beigene Recent Developments/Updates
Table 82. Beigene Competitive Strengths & Weaknesses
Table 83. Shanghai Junshi Biosciences Basic Information, Area Served and Competitors
Table 84. Shanghai Junshi Biosciences Major Business
Table 85. Shanghai Junshi Biosciences Monoclonal Antibody Drug Product and Services
Table 86. Shanghai Junshi Biosciences Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Shanghai Junshi Biosciences Recent Developments/Updates
Table 88. Shanghai Junshi Biosciences Competitive Strengths & Weaknesses
Table 89. Innovent Biologics Basic Information, Area Served and Competitors
Table 90. Innovent Biologics Major Business
Table 91. Innovent Biologics Monoclonal Antibody Drug Product and Services
Table 92. Innovent Biologics Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Innovent Biologics Recent Developments/Updates
Table 94. Innovent Biologics Competitive Strengths & Weaknesses
Table 95. WuXi Biologics (Cayman) Basic Information, Area Served and Competitors
Table 96. WuXi Biologics (Cayman) Major Business
Table 97. WuXi Biologics (Cayman) Monoclonal Antibody Drug Product and Services
Table 98. WuXi Biologics (Cayman) Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. WuXi Biologics (Cayman) Recent Developments/Updates
Table 100. WuXi Biologics (Cayman) Competitive Strengths & Weaknesses
Table 101. Shanghai Henlius Biotech Basic Information, Area Served and Competitors
Table 102. Shanghai Henlius Biotech Major Business
Table 103. Shanghai Henlius Biotech Monoclonal Antibody Drug Product and Services
Table 104. Shanghai Henlius Biotech Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Shanghai Henlius Biotech Recent Developments/Updates
Table 106. Shanghai Henlius Biotech Competitive Strengths & Weaknesses
Table 107. Akeso Basic Information, Area Served and Competitors
Table 108. Akeso Major Business
Table 109. Akeso Monoclonal Antibody Drug Product and Services
Table 110. Akeso Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Akeso Recent Developments/Updates
Table 112. Akeso Competitive Strengths & Weaknesses
Table 113. Lepu Biopharma Basic Information, Area Served and Competitors
Table 114. Lepu Biopharma Major Business
Table 115. Lepu Biopharma Monoclonal Antibody Drug Product and Services
Table 116. Lepu Biopharma Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Lepu Biopharma Recent Developments/Updates
Table 118. Lepu Biopharma Competitive Strengths & Weaknesses
Table 119. CStone Pharmaceuticals Basic Information, Area Served and Competitors
Table 120. CStone Pharmaceuticals Major Business
Table 121. CStone Pharmaceuticals Monoclonal Antibody Drug Product and Services
Table 122. CStone Pharmaceuticals Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. CStone Pharmaceuticals Recent Developments/Updates
Table 124. CStone Pharmaceuticals Competitive Strengths & Weaknesses
Table 125. Hillhouse Investment Management Basic Information, Area Served and Competitors
Table 126. Hillhouse Investment Management Major Business
Table 127. Hillhouse Investment Management Monoclonal Antibody Drug Product and Services
Table 128. Hillhouse Investment Management Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Hillhouse Investment Management Recent Developments/Updates
Table 130. Hillhouse Investment Management Competitive Strengths & Weaknesses
Table 131. Alphamab Oncology Basic Information, Area Served and Competitors
Table 132. Alphamab Oncology Major Business
Table 133. Alphamab Oncology Monoclonal Antibody Drug Product and Services
Table 134. Alphamab Oncology Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Alphamab Oncology Recent Developments/Updates
Table 136. Alphamab Oncology Competitive Strengths & Weaknesses
Table 137. Novartis Basic Information, Area Served and Competitors
Table 138. Novartis Major Business
Table 139. Novartis Monoclonal Antibody Drug Product and Services
Table 140. Novartis Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Novartis Recent Developments/Updates
Table 142. Takeda Pharmaceutical Basic Information, Area Served and Competitors
Table 143. Takeda Pharmaceutical Major Business
Table 144. Takeda Pharmaceutical Monoclonal Antibody Drug Product and Services
Table 145. Takeda Pharmaceutical Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 146. Global Key Players of Monoclonal Antibody Drug Upstream (Raw Materials)
Table 147. Monoclonal Antibody Drug Typical Customers
Table 1. World Monoclonal Antibody Drug Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Monoclonal Antibody Drug Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Monoclonal Antibody Drug Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Monoclonal Antibody Drug Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Monoclonal Antibody Drug Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Monoclonal Antibody Drug Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Monoclonal Antibody Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Monoclonal Antibody Drug Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Monoclonal Antibody Drug Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Monoclonal Antibody Drug Players in 2022
Table 12. World Monoclonal Antibody Drug Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Monoclonal Antibody Drug Company Evaluation Quadrant
Table 14. Head Office of Key Monoclonal Antibody Drug Player
Table 15. Monoclonal Antibody Drug Market: Company Product Type Footprint
Table 16. Monoclonal Antibody Drug Market: Company Product Application Footprint
Table 17. Monoclonal Antibody Drug Mergers & Acquisitions Activity
Table 18. United States VS China Monoclonal Antibody Drug Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Monoclonal Antibody Drug Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Monoclonal Antibody Drug Companies, Headquarters (States, Country)
Table 21. United States Based Companies Monoclonal Antibody Drug Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Monoclonal Antibody Drug Revenue Market Share (2018-2023)
Table 23. China Based Monoclonal Antibody Drug Companies, Headquarters (Province, Country)
Table 24. China Based Companies Monoclonal Antibody Drug Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Monoclonal Antibody Drug Revenue Market Share (2018-2023)
Table 26. Rest of World Based Monoclonal Antibody Drug Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Monoclonal Antibody Drug Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Monoclonal Antibody Drug Revenue Market Share (2018-2023)
Table 29. World Monoclonal Antibody Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Monoclonal Antibody Drug Market Size by Type (2018-2023) & (USD Million)
Table 31. World Monoclonal Antibody Drug Market Size by Type (2024-2029) & (USD Million)
Table 32. World Monoclonal Antibody Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Monoclonal Antibody Drug Market Size by Application (2018-2023) & (USD Million)
Table 34. World Monoclonal Antibody Drug Market Size by Application (2024-2029) & (USD Million)
Table 35. Abbott Basic Information, Area Served and Competitors
Table 36. Abbott Major Business
Table 37. Abbott Monoclonal Antibody Drug Product and Services
Table 38. Abbott Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Abbott Recent Developments/Updates
Table 40. Abbott Competitive Strengths & Weaknesses
Table 41. Johnson & Johnson Basic Information, Area Served and Competitors
Table 42. Johnson & Johnson Major Business
Table 43. Johnson & Johnson Monoclonal Antibody Drug Product and Services
Table 44. Johnson & Johnson Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Johnson & Johnson Recent Developments/Updates
Table 46. Johnson & Johnson Competitive Strengths & Weaknesses
Table 47. Roche Basic Information, Area Served and Competitors
Table 48. Roche Major Business
Table 49. Roche Monoclonal Antibody Drug Product and Services
Table 50. Roche Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Roche Recent Developments/Updates
Table 52. Roche Competitive Strengths & Weaknesses
Table 53. Ono Pharmaceutical Basic Information, Area Served and Competitors
Table 54. Ono Pharmaceutical Major Business
Table 55. Ono Pharmaceutical Monoclonal Antibody Drug Product and Services
Table 56. Ono Pharmaceutical Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Ono Pharmaceutical Recent Developments/Updates
Table 58. Ono Pharmaceutical Competitive Strengths & Weaknesses
Table 59. Amgen Basic Information, Area Served and Competitors
Table 60. Amgen Major Business
Table 61. Amgen Monoclonal Antibody Drug Product and Services
Table 62. Amgen Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Amgen Recent Developments/Updates
Table 64. Amgen Competitive Strengths & Weaknesses
Table 65. Merck Basic Information, Area Served and Competitors
Table 66. Merck Major Business
Table 67. Merck Monoclonal Antibody Drug Product and Services
Table 68. Merck Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Merck Recent Developments/Updates
Table 70. Merck Competitive Strengths & Weaknesses
Table 71. Jiangsu Hengrui Pharmaceuticals Basic Information, Area Served and Competitors
Table 72. Jiangsu Hengrui Pharmaceuticals Major Business
Table 73. Jiangsu Hengrui Pharmaceuticals Monoclonal Antibody Drug Product and Services
Table 74. Jiangsu Hengrui Pharmaceuticals Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
Table 76. Jiangsu Hengrui Pharmaceuticals Competitive Strengths & Weaknesses
Table 77. Beigene Basic Information, Area Served and Competitors
Table 78. Beigene Major Business
Table 79. Beigene Monoclonal Antibody Drug Product and Services
Table 80. Beigene Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Beigene Recent Developments/Updates
Table 82. Beigene Competitive Strengths & Weaknesses
Table 83. Shanghai Junshi Biosciences Basic Information, Area Served and Competitors
Table 84. Shanghai Junshi Biosciences Major Business
Table 85. Shanghai Junshi Biosciences Monoclonal Antibody Drug Product and Services
Table 86. Shanghai Junshi Biosciences Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Shanghai Junshi Biosciences Recent Developments/Updates
Table 88. Shanghai Junshi Biosciences Competitive Strengths & Weaknesses
Table 89. Innovent Biologics Basic Information, Area Served and Competitors
Table 90. Innovent Biologics Major Business
Table 91. Innovent Biologics Monoclonal Antibody Drug Product and Services
Table 92. Innovent Biologics Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Innovent Biologics Recent Developments/Updates
Table 94. Innovent Biologics Competitive Strengths & Weaknesses
Table 95. WuXi Biologics (Cayman) Basic Information, Area Served and Competitors
Table 96. WuXi Biologics (Cayman) Major Business
Table 97. WuXi Biologics (Cayman) Monoclonal Antibody Drug Product and Services
Table 98. WuXi Biologics (Cayman) Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. WuXi Biologics (Cayman) Recent Developments/Updates
Table 100. WuXi Biologics (Cayman) Competitive Strengths & Weaknesses
Table 101. Shanghai Henlius Biotech Basic Information, Area Served and Competitors
Table 102. Shanghai Henlius Biotech Major Business
Table 103. Shanghai Henlius Biotech Monoclonal Antibody Drug Product and Services
Table 104. Shanghai Henlius Biotech Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Shanghai Henlius Biotech Recent Developments/Updates
Table 106. Shanghai Henlius Biotech Competitive Strengths & Weaknesses
Table 107. Akeso Basic Information, Area Served and Competitors
Table 108. Akeso Major Business
Table 109. Akeso Monoclonal Antibody Drug Product and Services
Table 110. Akeso Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Akeso Recent Developments/Updates
Table 112. Akeso Competitive Strengths & Weaknesses
Table 113. Lepu Biopharma Basic Information, Area Served and Competitors
Table 114. Lepu Biopharma Major Business
Table 115. Lepu Biopharma Monoclonal Antibody Drug Product and Services
Table 116. Lepu Biopharma Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Lepu Biopharma Recent Developments/Updates
Table 118. Lepu Biopharma Competitive Strengths & Weaknesses
Table 119. CStone Pharmaceuticals Basic Information, Area Served and Competitors
Table 120. CStone Pharmaceuticals Major Business
Table 121. CStone Pharmaceuticals Monoclonal Antibody Drug Product and Services
Table 122. CStone Pharmaceuticals Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. CStone Pharmaceuticals Recent Developments/Updates
Table 124. CStone Pharmaceuticals Competitive Strengths & Weaknesses
Table 125. Hillhouse Investment Management Basic Information, Area Served and Competitors
Table 126. Hillhouse Investment Management Major Business
Table 127. Hillhouse Investment Management Monoclonal Antibody Drug Product and Services
Table 128. Hillhouse Investment Management Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Hillhouse Investment Management Recent Developments/Updates
Table 130. Hillhouse Investment Management Competitive Strengths & Weaknesses
Table 131. Alphamab Oncology Basic Information, Area Served and Competitors
Table 132. Alphamab Oncology Major Business
Table 133. Alphamab Oncology Monoclonal Antibody Drug Product and Services
Table 134. Alphamab Oncology Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Alphamab Oncology Recent Developments/Updates
Table 136. Alphamab Oncology Competitive Strengths & Weaknesses
Table 137. Novartis Basic Information, Area Served and Competitors
Table 138. Novartis Major Business
Table 139. Novartis Monoclonal Antibody Drug Product and Services
Table 140. Novartis Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Novartis Recent Developments/Updates
Table 142. Takeda Pharmaceutical Basic Information, Area Served and Competitors
Table 143. Takeda Pharmaceutical Major Business
Table 144. Takeda Pharmaceutical Monoclonal Antibody Drug Product and Services
Table 145. Takeda Pharmaceutical Monoclonal Antibody Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 146. Global Key Players of Monoclonal Antibody Drug Upstream (Raw Materials)
Table 147. Monoclonal Antibody Drug Typical Customers
LIST OF FIGURES
Figure 1. Monoclonal Antibody Drug Picture
Figure 2. World Monoclonal Antibody Drug Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Monoclonal Antibody Drug Total Market Size (2018-2029) & (USD Million)
Figure 4. World Monoclonal Antibody Drug Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Monoclonal Antibody Drug Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Monoclonal Antibody Drug Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Monoclonal Antibody Drug Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Monoclonal Antibody Drug Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Monoclonal Antibody Drug Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Monoclonal Antibody Drug Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Monoclonal Antibody Drug Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Monoclonal Antibody Drug Revenue (2018-2029) & (USD Million)
Figure 13. Monoclonal Antibody Drug Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Monoclonal Antibody Drug Consumption Value (2018-2029) & (USD Million)
Figure 16. World Monoclonal Antibody Drug Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Monoclonal Antibody Drug Consumption Value (2018-2029) & (USD Million)
Figure 18. China Monoclonal Antibody Drug Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Monoclonal Antibody Drug Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Monoclonal Antibody Drug Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Monoclonal Antibody Drug Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Monoclonal Antibody Drug Consumption Value (2018-2029) & (USD Million)
Figure 23. India Monoclonal Antibody Drug Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Monoclonal Antibody Drug by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Monoclonal Antibody Drug Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Monoclonal Antibody Drug Markets in 2022
Figure 27. United States VS China: Monoclonal Antibody Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Monoclonal Antibody Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Monoclonal Antibody Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Monoclonal Antibody Drug Market Size Market Share by Type in 2022
Figure 31. Humanized Monoclonal Antibody Drugs
Figure 32. Fully Human Monoclonal Antibody Drugs
Figure 33. Small Molecule Antibody Drugs
Figure 34. Chimeric Monoclonal Antibody Drugs
Figure 35. Other
Figure 36. World Monoclonal Antibody Drug Market Size Market Share by Type (2018-2029)
Figure 37. World Monoclonal Antibody Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 38. World Monoclonal Antibody Drug Market Size Market Share by Application in 2022
Figure 39. Cancer Treatment
Figure 40. Autoimmune Disease Treatment
Figure 41. Monoclonal Antibody Drug Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source
Figure 1. Monoclonal Antibody Drug Picture
Figure 2. World Monoclonal Antibody Drug Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Monoclonal Antibody Drug Total Market Size (2018-2029) & (USD Million)
Figure 4. World Monoclonal Antibody Drug Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Monoclonal Antibody Drug Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Monoclonal Antibody Drug Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Monoclonal Antibody Drug Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Monoclonal Antibody Drug Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Monoclonal Antibody Drug Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Monoclonal Antibody Drug Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Monoclonal Antibody Drug Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Monoclonal Antibody Drug Revenue (2018-2029) & (USD Million)
Figure 13. Monoclonal Antibody Drug Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Monoclonal Antibody Drug Consumption Value (2018-2029) & (USD Million)
Figure 16. World Monoclonal Antibody Drug Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Monoclonal Antibody Drug Consumption Value (2018-2029) & (USD Million)
Figure 18. China Monoclonal Antibody Drug Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Monoclonal Antibody Drug Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Monoclonal Antibody Drug Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Monoclonal Antibody Drug Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Monoclonal Antibody Drug Consumption Value (2018-2029) & (USD Million)
Figure 23. India Monoclonal Antibody Drug Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Monoclonal Antibody Drug by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Monoclonal Antibody Drug Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Monoclonal Antibody Drug Markets in 2022
Figure 27. United States VS China: Monoclonal Antibody Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Monoclonal Antibody Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Monoclonal Antibody Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Monoclonal Antibody Drug Market Size Market Share by Type in 2022
Figure 31. Humanized Monoclonal Antibody Drugs
Figure 32. Fully Human Monoclonal Antibody Drugs
Figure 33. Small Molecule Antibody Drugs
Figure 34. Chimeric Monoclonal Antibody Drugs
Figure 35. Other
Figure 36. World Monoclonal Antibody Drug Market Size Market Share by Type (2018-2029)
Figure 37. World Monoclonal Antibody Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 38. World Monoclonal Antibody Drug Market Size Market Share by Application in 2022
Figure 39. Cancer Treatment
Figure 40. Autoimmune Disease Treatment
Figure 41. Monoclonal Antibody Drug Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source
